The business earned $167.30 million during the quarter, compared to. Salt lake city, ut, 84108.
Close price at the end of the last trading day (friday, 12th nov 2021) of the mygn stock was $30.24.
Myriad genetics stock forecast. Myriad genetics inc has risen higher in 11 of those 26 years over the subsequent 52 week period, corresponding to a historical accuracy of 42.31 %. According to ai pickup, the myriad genetics stock price forecast for 2021 dec. That tiny $240 million company now has a market cap of $4.5 billion compared to myriad genetics with a $2.5 billion market cap.
(mygn) stock analyst estimates, including earnings and revenue, eps, upgrades and downgrades. Stock price forecast for 2023: The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
Stock price forecast for 2023: The average myriad genetics stock price prediction forecasts a potential downside of n/a from the current mygn share price of $27.51. As is evident from the statistics, the company’s shares have risen +137.81 percent over the past six months.
Get our premium forecast now, from only $8.49! That was a remarkable call mr. As for revenue growth, invitae is quickly catching up to myriad which hasn’t been able to grow revenues for ten quarters in a row now.
Over the next 52 weeks, myriad genetics inc has on average historically risen by 47.1 % based on the past 26 years of stock performance. According to the last reported balance sheet, myriad genetics had liabilities of us$271.0m due within 12 months, and liabilities of us$186.9m due beyond 12 months. In recent trading, shares of myriad genetics, inc.
Souda now forecasts that the company will post earnings per share of ($0.40) for the year, down from their prior estimate of ($0.39). Myriad genetics inc stock forecast. The reported ($0.02) eps for the quarter, hitting analysts' consensus estimates of ($0.02).
During the day the stock fluctuated 5.41% from a day low at $30.14 to a day high of $31.77. From myriad genetics stock forecast , myriad genetics (mygn) stock cannot be a good investment choice. Find the latest news for myriad genetics stock on our page and stay on top of the game.
This is 4.03% less than the trading day before thursday, 11th nov 2021. Myriad genetics's share price could stay at $30.00 by nov 3, 2022. Myriad genetics last announced its earnings results on november 2nd, 2021.
Stock forecast, mygn stock predictons by days: Since then, mygn stock has increased by 123.0% and is now trading at $31.28. Stock price forecast for 2023:
On average, analysts expect that myriad genetics will report full year earnings of $0.02 per share for the current financial year, with eps estimates ranging from ($0.02) to $0.04. For the next fiscal year, analysts forecast that the business will post earnings of $0.23 per share, with eps estimates ranging from $0.15 to $0.30. Share prices are performing particularly well compared to other companies within the same industry.
$167.3 million in q3 vs. On average, wall street analysts predict that.
